Terms: = Kidney tumors AND KAT6B, DKFZp313G1618, 23522, MYST4, ENSG00000156650, Q8WYB5, querkopf, qkf, MOZ2, MORF, KIAA0383, FLJ90335
4 results:
1. Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma.
Liang F; Li X; Shen X; Yang R; Chen C
BMC Cancer; 2023 Jun; 23(1):586. PubMed ID: 37365518
[TBL] [Abstract] [Full Text] [Related]
2. A preclinical 188Re tumor therapeutic investigation using morf/cmorf pretargeting and an antiTAG-72 antibody CC49.
Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
[TBL] [Abstract] [Full Text] [Related]
4. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
[TBL] [Abstract] [Full Text] [Related]
